FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nikolai Naoumov

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Livers

Physiology

Procedures

Liver Transplantation

Co-author Network

Publications

TOP 3
Richard S Tedder; Mark Thursz; Roger Williams; Terry Wong; Mark Wright; Michael Anderson; Jangu Banatvala; Margaret Bassendine; Andrew Bathgate; George Bird; Shilpa Chokshi; Jane Collier; John F Dillon; Geoffrey Dusheiko; Lori Fries; Hyder Hussaini; Samreen Ijaz; Michael Jacobs; Anne M Johnson; Peter R Mills; Sulleman Moreea; David Mutimer; Nikolai Naoumov; Alison J Rodger; Gillian Rosenberg; William Rosenberg; Stephen D Ryder
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Sandra Phillips; Shilpa Chokshi; Antonio Riva; Alexander Evans; Roger Williams; Nikolai Naoumov
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Stefan Zeuzem; Edward Gane; Yun-Fan Liaw; Seng G Lim; Adrian DiBisceglie; Maria Buti; Anuchit Chutaputti; Jens Rasenack; Jinlin Hou; Christopher B O'Brien; Tuan T Nguyen; Jidong Jia; Thierry Poynard; Bruce Belanger; Weibin Bao; Nikolai Naoumov
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nikolai Naoumov (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard S Tedder; Mark Thursz; Roger Williams; Terry Wong; Mark Wright; Michael Anderson; Jangu Banatvala; Margaret Bassendine; Andrew Bathgate; George Bird; Shilpa Chokshi; Jane Collier; John F Dillon; Geoffrey Dusheiko; Lori Fries; Hyder Hussaini; Samreen Ijaz; Michael Jacobs; Anne M Johnson; Peter R Mills; Sulleman Moreea; David Mutimer; Nikolai Naoumov; Alison J Rodger; Gillian Rosenberg; William Rosenberg; Stephen D Ryder
The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(7):951-60.
2010: Sandra Phillips; Shilpa Chokshi; Antonio Riva; Alexander Evans; Roger Williams; Nikolai Naoumov
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(1):287-95.
2009: Stefan Zeuzem; Edward Gane; Yun-Fan Liaw; Seng G Lim; Adrian DiBisceglie; Maria Buti; Anuchit Chutaputti; Jens Rasenack; Jinlin Hou; Christopher B O'Brien; Tuan T Nguyen; Jidong Jia; Thierry Poynard; Bruce Belanger; Weibin Bao; Nikolai Naoumov
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.
Journal of hepatology 2009;51(1):11-20.
2009: Ioannis Pachiadakis; Shilpa Chokshi; Helen Cooksley; Dimitrios Farmakiotis; Christoph Sarrazin; Stefan Zeuzem; Tomasz I Michalak; Nikolai Naoumov
Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.
Clinical immunology (Orlando, Fla.) 2009;131(3):415-25.
2009: Yun-Fan Liaw; Edward Gane; Nancy Leung; Stefan Zeuzem; Yuming Wang; Ching Lung Lai; E Jenny Heathcote; Michael Manns; Natalie Bzowej; Junqi Niu; Steven-Huy Han; Seong Gyu Hwang; YILMAZ CAKALOGLU; Myron J Tong; George Papatheodoridis; Yagang Chen; Nathaniel A Brown; Efsevia Albanis; Karin Galil; Nikolai Naoumov
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Gastroenterology 2009;136(2):486-95.
2008: Prem H Thurairajah; Doha Hegazy; Shilpa Chokshi; Steve Shaw; Andrew Demaine; Edward R Kaminski; Nikolai Naoumov; Matthew E Cramp
Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
The Journal of infectious diseases 2008;198(12):1749-55.
2008: Fuat Kurbanov; Yasuhito Tanaka; Elena Chub; Isao Maruyama; Aziza Azlarova; Hiroshi Kamitsukasa; Tomoyoshi Ohno; Stefania Bonetto; Isabelle Moreau; Liam Fanning; Florence Legrand-Abravanel; Jacques Izopet; Nikolai Naoumov; Takashi Shimada; Sergey V Netesov; Masashi Mizokami
Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
The Journal of infectious diseases 2008;198(10):1448-56.
2008: Alexander Evans; Antonio Riva; Helen Cooksley; Sandra Phillips; Smrithi Puranik; Amit Nathwani; Sara Brett; Shilpa Chokshi; Nikolai Naoumov
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
Hepatology (Baltimore, Md.) 2008;48(3):759-69.
2008: Samreen Ijaz; Catherine Arnold; Samir Dervisevic; Jana Mechurova; Nick Tatman; Richard S Tedder; Nikolai Naoumov
Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.
Journal of medical virology 2008;80(7):1160-70.
2008: Sandra Proto; John A Taylor; Shilpa Chokshi; Naveenan Navaratnam; Nikolai Naoumov
APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
Antiviral research 2008;78(3):260-7.
2008: Kwok H Tang; E Herrmann; Ioannis Pachiadakis; Emma Paulon; N Tatman; Stefan Zeuzem; Nikolai Naoumov
Clinical trial: individualized treatment duration for hepatitis C virus genotype 1 with peginterferon-alpha 2a plus ribavirin.
Alimentary pharmacology & therapeutics 2008;27(9):810-9.
2008: Chee-Kin Hui; Hai-Ying Zhang; Scott Bowden; Stephen Locarnini; John Luk; Kit-Wah Leung; Yui-Hung Yueng; April Wong; Franck Rousseau; Kwok-Yung Yuen; Nikolai Naoumov; George K K Lau
96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B.
Journal of hepatology 2008;48(5):714-20.
2008: Ausra Guobuzaite; Shilpa Chokshi; Ligita Balciūniene; Alina Voinic; Ausra Stikleryte; Kestutis Zagminas; Arvydas Ambrozaitis; Nikolai Naoumov
Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.
Medicina (Kaunas, Lithuania) 2008;44(7):510-20.
2008: Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai Naoumov
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.
Antimicrobial agents and chemotherapy 2008;52(1):312-20.
2007: Ching-Lung Lai; Edward Gane; Yun-Fan Liaw; Chao-Wei Hsu; Satawat Thongsawat; Yuming Wang; Yagang Chen; E Jenny Heathcote; Jens Rasenack; Natalie Bzowej; Nikolai Naoumov; Adrian M Di Bisceglie; Stefan Zeuzem; Young Myoung Moon; Zachary Goodman; George Chao; Barbara Fielman Constance; Nathaniel A Brown
Telbivudine versus lamivudine in patients with chronic hepatitis B.
The New England journal of medicine 2007;357(25):2576-88.
2007: Francesca Dal Pero; Kwok H Tang; Martina Gerotto; Gladis Bortoletto; Emma Paulon; Eva Herrmann; Stefan Zeuzem; Alfredo Alberti; Nikolai Naoumov
Impact of NS5A sequences of Hepatitis C virus genotype 1a on early viral kinetics during treatment with peginterferon- alpha 2a plus ribavirin.
The Journal of infectious diseases 2007;196(7):998-1005.
2007: Emmet B Keeffe; Stefan Zeuzem; Raymond S Koff; Douglas T Dieterich; Rafael Esteban-Mur; Edward Gane; Ira M Jacobson; Seng Gee Lim; Nikolai Naoumov; Patrick Marcellin; Teerha Piratvisuth; Fabien Zoulim
Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007;5(8):890-7.
2007: Jinlin Hou; Ralf Schilling; Harry L A Janssen; Bettina E Hansen; Rudolf Heijtink; Erwin Sablon; Roger Williams; George K K Lau; Solko W Schalm; Nikolai Naoumov
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.
Journal of medical virology 2007;79(8):1055-63.
2007: R Bridget Ferns; Nikolai Naoumov; Richard Gilson; Richard S Tedder
Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;39(3):199-204.
2007: Eirini I Rigopoulou; William G H Abbott; Roger Williams; Nikolai Naoumov
Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Antiviral research 2007;75(1):36-42.
2007: Z Wang; J Hou; G Zeng; S Wen; Y Tanaka; J Cheng; Fuat Kurbanov; L Wang; J Jiang; Nikolai Naoumov; M Mizokami; Y Qi
Distribution and characteristics of hepatitis B virus genotype C subgenotypes in China.
Journal of viral hepatitis 2007;14(6):426-34.
2007: Barbara Rehermann; Nikolai Naoumov
Immunological techniques in viral hepatitis.
Journal of hepatology 2007;46(3):508-20.
2007: Christian B Willberg; Scott M Ward; Reginald F Clayton; Nikolai Naoumov; Christopher McCormick; Sandra Proto; Mark Harris; Arvind H Patel; Paul Klenerman
Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha.
PloS one 2007;2(8):e791.
2007: George K K Lau; Helen Cooksley; Ruy M Ribeiro; Kimberly A Powers; Emi Shudo; Scott Bowden; Chee-Kin Hui; Jane Anderson; Jeff Sorbel; Elsa Mondou; Franck Rousseau; Sharon Lewin; Alan S Perelson; Stephen Locornini; Nikolai Naoumov
Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
Antiviral therapy 2007;12(5):705-18.
2006: Chee-Kin Hui; Scott Bowden; Hai-Ying Zhang; Anita Wong; Sharon Lewin; Franck Rousseau; Herve Mommeja-Marin; Nikki P Y Lee; John Luk; Stephen Locarnini; Nancy Leung; Nikolai Naoumov; George K K Lau
Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy.
Journal of clinical microbiology 2006;44(8):2983-7.
2006: Emma Paulon; Nikolai Naoumov
Individualization of antiviral treatment regimens for chronic hepatitis C.
European journal of gastroenterology & hepatology 2006;18(4):321-5.
2006: Robert P Perrillo; Robert G Gish; Marion Peters; Emmet B Keeffe; Alfredo Alberti; Maria Buti; W Graham E Cooksley; Michael W Fried; Stephanos J Hadziyannis; Yun-Fan Liaw; Nikolai Naoumov; Eugene R Schiff; Chloe L Thio; Naoky Tsai; Solko Schalm
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(2):233-48.
2005: G Zeng; Z Wang; S Wen; J Jiang; L Wang; J Cheng; D Tan; F Xiao; S Ma; W Li; Kangxian Luo; Nikolai Naoumov; Jinlin Hou
Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
Journal of viral hepatitis 2005;12(6):609-17.
2005: Kei Fujiwara; Yasuhito Tanaka; Emma Paulon; Etsuro Orito; Masaya Sugiyama; Kiyoaki Ito; Ryuzo Ueda; Masashi Mizokami; Nikolai Naoumov
Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
Journal of virology 2005;79(22):14404-10.
2005: Eirini I Rigopoulou; Deepak Suri; Shilpa Chokshi; Ivana Mullerova; Steven Rice; Richard S Tedder; Roger Williams; Nikolai Naoumov
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.
Hepatology (Baltimore, Md.) 2005;42(5):1028-36.
2005: Kwok H Tang; Eva Herrmann; Helen Cooksley; Nick Tatman; Shilpa Chokshi; Roger Williams; Stefan Zeuzem; Nikolai Naoumov
Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.
Journal of hepatology 2005;43(5):776-82.
2005: Ute-Christiane Meier; Rachel E Owen; Elizabeth Taylor; Andrew Worth; Nikolai Naoumov; Christian B Willberg; Kwok Tang; Philippa Newton; Pierre Pellegrino; Ian Williams; Paul Klenerman; Persephone Borrow
Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections.
Journal of virology 2005;79(19):12365-74.
2005: Eirini I Rigopoulou; William G H Abbott; Philip Haigh; Nikolai Naoumov
Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.
Clinical immunology (Orlando, Fla.) 2005;117(1):57-64.
2005: Ioannis Pachiadakis; Gabriele Pollara; Benjamin M Chain; Nikolai Naoumov
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
The Lancet infectious diseases 2005;5(5):296-304.
2005: Zhanhui Wang; Zhihua Liu; Guobing Zeng; Shujuan Wen; Yipeng Qi; Shiwu Ma; Nikolai Naoumov; Jinlin Hou
A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China.
The Journal of general virology 2005;86(Pt 4):985-90.
2005: Massimiliano Loreno; Patrizio Bo; Marco Senzolo; Umberto Cillo; Nikolai Naoumov; Marco Senzolo
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.
Transplant international : official journal of the European Society for Organ Transplantation 2005;17(11):730-4.
2005: M Wright; Daniel Forton; Janice Main; Robert Goldin; Mili Estee Torok; R Tedder; P Grant; Mark Thursz; Nikolai Naoumov; C Millson; P R Mills; Margaret F Bassendine; Howard Thomas
Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial.
Journal of viral hepatitis 2005;12(1):58-66.
2005: John A Taylor; Nikolai Naoumov
The potential of RNA interference as a tool in the management of viral hepatitis.
Journal of hepatology 2005;42(1):139-44.
2004: Tram N Q Pham; Sonya A MacParland; Patricia Mulrooney-Cousins; Helen Cooksley; Nikolai Naoumov; Tomasz I Michalak
Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.
Journal of virology 2004;78(11):5867-74.
2004: William G H Abbott; Eirini I Rigopoulou; Philip Haigh; Helen Cooksley; Ivana Mullerova; Marco Novelli; Alison M Winstanley; Roger Williams; Nikolai Naoumov
Single nucleotide polymorphisms in the interferon-gamma and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus.
Liver international : official journal of the International Association for the Study of the Liver 2004;24(2):90-7.
2004: Francesco Torre; Matthew Cramp; Ania M Owsianka; Ed Dornan; Howard Marsden; William F Carman; Roger Williams; Nikolai Naoumov
Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.
Journal of medical virology 2004;72(3):370-6.
2004: Debbie L Shawcross; Nikolai Naoumov; Ioannis Pachiadakis; Constantinos Mamais; Roger Williams; Rajiv Jalan; Alice R Gillams; William R Lees
Should a biopsy precede liver resection or transplantation for presumed hepatocellular carcinoma when the alfa fetoprotein is normal?
Transplantation 2004;77(4):637-8.
2004: Shilpa Chokshi; Nikolai Naoumov
In vitro analysis of hepatitis B virus specific CD4+ T cells.
Methods in molecular medicine 2004;96():97-109.
2003: Ralf Schilling; Samreen Ijaz; Michail Davidoff; Jia-Yee Lee; Stephen Locarnini; Roger Williams; Nikolai Naoumov
Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions.
Journal of virology 2003;77(16):8882-92.
2003: Antonio Bertoletti; Nikolai Naoumov
Translation of immunological knowledge into better treatments of chronic hepatitis B.
Journal of hepatology 2003;39(1):115-24.
2003: Ivana Kráslová; Libor Vítek; Lucie Muchová; Nikolai Naoumov
[New views on immunopathology of viral hepatitis B and C].
Casopís lékar̆ů c̆eských 2003;142(10):590-4.
2002: Nikolai Naoumov
Assessment and management of chronic hepatitis B.
Clinical medicine (London, England) 2002;2(4):306-10.
2002: Nikolai Naoumov
SEN viruses and treatment response in chronic hepatitis C virus.
Lancet 2002;359(9319):1779-80; author reply 1780.
2002: George K K Lau; Deepak Suri; Raymond Liang; Eirini I Rigopoulou; Mark Thomas; Ivana Mullerova; Amin A Nanji; Siu Tsan Yuen; Roger Williams; Nikolai Naoumov
Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
Gastroenterology 2002;122(3):614-24.
2001: Deepak Suri; Ralf Schilling; Agnel Ross Lopes; Ivana Mullerova; G Colucci; Roger Williams; Nikolai Naoumov
Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes.
Journal of hepatology 2001;35(6):790-7.
2001: Simona Caronia; M F Bassendine; R Barry; P Mills; Nikolai Naoumov; R Fox; J Lowes; D Hollanders; L Murray-Lyon; W L Irving; Robert Goldin; Graham R Foster
Interferon plus amantadine versus interferon alone in the treatment of naïve patients with chronic hepatitis C: a UK multicentre study.
Journal of hepatology 2001;35(4):512-6.
2001: K Bjøro; E P Petrova; Mark Thomas; S S Frøland; R Williams; Nikolai Naoumov
TT virus infection in patients with primary hypogammaglobulinaemia: natural history and relationship to liver disease in the immunocompromised host.
Scandinavian journal of gastroenterology 2001;36(9):987-93.
2001: Nikolai Naoumov; Agnel Ross Lopes; Marco Senzolo; Lucio Caccamo; Rosa Maria Iemmolo; R A de Man; M Bassendine; John G O'Grady; Bernard Portmann; G Anschuetz; C A Barrett; Roger Williams; M Atkins
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Journal of hepatology 2001;34(6):888-94.
2001: Samreen Ijaz; Francesco Torre; Richard S Tedder; Roger Williams; Nikolai Naoumov
Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
Journal of medical virology 2001;63(3):210-6.
2000: Nikolai Naoumov
TT virus--highly prevalent, but still in search of a disease.
Journal of hepatology 2000;33(1):157-9.
2000: Mala K Maini; C Boni; C K Lee; J R Larrubia; Stephanie Reignat; Graham S Ogg; Abigail S Bailey; J Herberg; Richard Gilson; Akeel Alisa; Roger Williams; Diego Vergani; Nikolai Naoumov; Carlo Ferrari; Antonio Bertoletti
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.
The Journal of experimental medicine 2000;191(8):1269-80.
2000: G Marinos; Siegbert Rossol; P Carucci; P Y Wong; P Donaldson; Munther J Hussain; D Vergani; B C Portmann; Roger Williams; Nikolai Naoumov
Immunopathogenesis of hepatitis B virus recurrence after liver transplantation.
Transplantation 2000;69(4):559-68.
2000: Matthew E Cramp; Siegbert Rossol; Shilpa Chokshi; P Carucci; Roger Williams; Nikolai Naoumov
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Gastroenterology 2000;118(2):346-55.
1999: Nikolai Naoumov
Hepatitis C virus-specific CD4(+) T cells: do they help or damage?
Gastroenterology 1999;117(4):1012-4.
1999: Francesco Torre; P Y Wong; M Macartney; Roger Williams; Nikolai Naoumov
Evolution of wild-type and precore mutant HBV infection after liver transplantation.
Journal of medical virology 1999;59(1):5-13.
1999: Harry L A Janssen; G Gerken; V Carreño; P Marcellin; Nikolai Naoumov; A Craxi; H Ring-Larsen; G Kitis; Jan van Hattum; Richard A de Vries; Peter P Michielsen; Fiebo J W Ten Kate; Wim C J Hop; Rudolf Heijtink; Pieter Honkoop; Solko W Schalm
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).
Hepatology (Baltimore, Md.) 1999;30(1):238-43.
1999: Matthew E Cramp; P Carucci; Siegbert Rossol; Shilpa Chokshi; Geert Maertens; Roger Williams; Nikolai Naoumov
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia.
Gut 1999;44(3):424-9.
1999: Edward Gane; Geert Maertens; A Ducatteeuw; K P Qian; J Y Lau; H Jones; E Davies; Nikolai Naoumov; Roger Williams
Antibodies to hepatitis C virus envelope proteins correlate with hepatitis C viraemia after liver transplantation.
Transplantation 1999;67(1):78-84.
1999: Nikolai Naoumov
Hepatitis C virus infection in Eastern Europe.
Journal of hepatology 1999;31 Suppl 1():84-7.
1998: Francesco Torre; Nikolai Naoumov
Clinical implications of mutations in the hepatitis B virus genome.
European journal of clinical investigation 1998;28(8):604-14.
1998: Matthew E Cramp; P Carucci; James Underhill; Nikolai Naoumov; Roger Williams; Peter T Donaldson
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
Journal of hepatology 1998;29(2):207-13.
1998: C Bréchot; F Jaffredo; D Lagorce; G Gerken; K Meyer zum Büschenfelde; A Papakonstontinou; S Hadziyannis; R Romeo; M Colombo; Juan Rodes; Jordi Bruix; R Williams; Nikolai Naoumov
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Journal of hepatology 1998;29(2):173-83.
1998: Nikolai Naoumov; E P Petrova; Mark Thomas; Roger Williams
Presence of a newly described human DNA virus (TTV) in patients with liver disease.
Lancet 1998;352(9123):195-7.
1998: David Mutimer; Nikolai Naoumov; P Honkoop; G Marinos; M Ahmed; R de Man; P McPhillips; M Johnson; R Williams; Elwyn Elias; S Schalm
Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study.
Journal of hepatology 1998;28(6):923-9.
1998: Edward Gane; S K Lo; S M Riordan; Bernard Portmann; J Y Lau; Nikolai Naoumov; Roger Williams
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Hepatology (Baltimore, Md.) 1998;27(5):1403-7.
1997: Nikolai Naoumov; K A Antonov; S Miska; V Bichko; Roger Williams; H Will
Differentiation of core gene products of the hepatitis B virus in infected liver tissue using monoclonal antibodies.
Journal of medical virology 1997;53(2):127-38.
1997: I Nagata; N Tzampouras; Shilpa Chokshi; Nikolai Naoumov; P Cheeseman; H M Smith; A J Baker; Roger Williams; Giorgina Mieli-Vergani
Hepatitis GB virus-C/hepatitis G virus infection in liver disease.
Archives of disease in childhood 1997;77(3):223-6.
1997: Nikolai Naoumov; Shilpa Chokshi; E Metivier; Geert Maertens; P J Johnson; Roger Williams
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.
Journal of hepatology 1997;27(2):331-6.
1997: Siegbert Rossol; G Marinos; P Carucci; Manfred V Singer; Roger Williams; Nikolai Naoumov
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B.
The Journal of clinical investigation 1997;99(12):3025-33.
1997: Martina Sterneck; Stephan Günther; J Gerlach; Nikolai Naoumov; Teresa Santantonio; L Fischer; X Rogiers; Heiner Greten; R Williams; Hans Will
Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis.
Journal of hepatology 1997;26(4):754-64.
1997: Nikolai Naoumov; Siegbert Rossol
Studies of interleukin-12 in chronic hepatitis B virus infection.
Journal of viral hepatitis 1997;4 Suppl 2():87-91.
1996: A Mason; R Sallie; Robert P Perrillo; A Rayner; Lizhe Xu; D E Dohner; M Dehner; Nikolai Naoumov; L Gelb; B Saha; J O'Grady; R Williams
Prevalence of herpesviridae and hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure.
Hepatology (Baltimore, Md.) 1996;24(6):1361-5.
1996: G Marinos; Nikolai Naoumov; Roger Williams
Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 1996;24(5):991-5.
1996: G Marinos; Francesco Torre; Stephan Günther; Mark Thomas; Hans Will; Roger Williams; Nikolai Naoumov
Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
Gastroenterology 1996;111(1):183-92.
1996: Stephen D Ryder; P M Rizzi; Martin Volkmann; E Metivier; Leila M M B Pereira; Peter R Galle; Nikolai Naoumov; Hanswalter Zentgraf; Roger Williams
Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma.
Journal of clinical pathology 1996;49(4):295-9.
1996: Edward Gane; Bernard Portmann; Nikolai Naoumov; H M Smith; James Underhill; Peter T Donaldson; Geert Maertens; Roger Williams
Long-term outcome of hepatitis C infection after liver transplantation.
The New England journal of medicine 1996;334(13):815-20.
1996: P M Rizzi; Stephen D Ryder; Bernard Portmann; J K Ramage; Nikolai Naoumov; Roger Williams
p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
Gut 1996;38(2):265-8.
1996: Edward Gane; Nikolai Naoumov; K P Qian; M U Mondelli; Geert Maertens; Bernard Portmann; Johnson Y N Lau; Roger Williams
A longitudinal analysis of hepatitis C virus replication following liver transplantation.
Gastroenterology 1996;110(1):167-77.
1995: M Vivarelli; H M Smith; Nikolai Naoumov; Roger Williams
Quantitative assessment of serum beta-2-microglobulin in liver transplant recipients and relationship to liver graft rejection.
European journal of gastroenterology & hepatology 1995;7(12):1215-9.
1995: P Y Wong; G Marinos; M Peakman; J Michael Tredger; Johnson Y N Lau; D Vergani; Nikolai Naoumov; Roger Williams
FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1995;1(6):362-70.
1995: G Marinos; Francesco Torre; Shilpa Chokshi; M Hussain; B E Clarke; D J Rowlands; A L Eddleston; Nikolai Naoumov; Roger Williams
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1040-9.
1995: Stephen D Ryder; J Koskinas; P M Rizzi; I G McFarlane; Bernard Portmann; Nikolai Naoumov; Roger Williams
Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus.
Hepatology (Baltimore, Md.) 1995;22(3):718-22.
1995: AN McNair; P Viaggi; H M Smith; C J Tibbs; Nikolai Naoumov; Roger Williams
Hepatitis B envelope protein mutants.
Lancet 1995;346(8970):318-9.
1995: B M McFarlane; C B Bridger; H M Smith; K A Antonov; Nikolai Naoumov; Roger Williams; I G McFarlane
Autoimmune mechanisms in chronic hepatitis B and delta virus infections.
European journal of gastroenterology & hepatology 1995;7(7):615-21.
1995: B A Farhat; G Marinos; H M Daniels; Nikolai Naoumov; Roger Williams
Evaluation of efficacy and safety of thymus humoral factor-gamma 2 in the management of chronic hepatitis B.
Journal of hepatology 1995;23(1):21-7.
1995: G Marinos; Nikolai Naoumov; Siegbert Rossol; Francesco Torre; P Y Wong; H Gallati; Bernard Portmann; Roger Williams
Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
Gastroenterology 1995;108(5):1453-63.
1995: Nikolai Naoumov; Mark Thomas; Andrew L Mason; Shilpa Chokshi; C J Bodicky; F Farzaneh; Roger Williams; Robert P Perrillo
Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.
Gastroenterology 1995;108(2):505-14.
1995: P Y Wong; J R McPeake; Bernard Portmann; K C Tan; Nikolai Naoumov; Roger Williams
Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma.
The American journal of gastroenterology 1995;90(1):29-34.
1994: Nikolai Naoumov; A L Eddleston
Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus.
Gut 1994;35(8):1013-7.
1994: G Marinos; H M Smith; Nikolai Naoumov; Roger Williams
Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
Hepatology (Baltimore, Md.) 1994;19(2):303-11.
1993: A M Ackrill; Nikolai Naoumov; A L Eddleston; Roger Williams
Specific deletions in the hepatitis B virus core open reading frame in patients with chronic active hepatitis B.
Journal of medical virology 1993;41(2):165-9.
1993: Nikolai Naoumov; H M Daniels; F Davison; A L Eddleston; Graeme J M Alexander; Roger Williams
Identification of hepatitis B virus-DNA in the liver by in situ hybridization using a biotinylated probe. Relation to HBcAg expression and histology.
Journal of hepatology 1993;19(2):204-10.
1993: Johnson Y N Lau; G L Bird; Nikolai Naoumov; R Williams
Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
Digestive diseases and sciences 1993;38(5):888-95.
1993: R Sallie; A Rayner; Nikolai Naoumov; Bernard Portmann; R Williams
Occult HBV in NANB fulminant hepatitis.
Lancet 1993;341(8837):123.
1992: A M Ackrill; Nikolai Naoumov; A L Eddleston; Roger Williams
Comparison of pre-core/core hepatitis B virus region in liver tissue and serum from patients with chronic hepatitis B infection.
Journal of hepatology 1992;16(1-2):224-7.
1992: Joachim C Arnold; Bernard Portmann; John G O'Grady; Nikolai Naoumov; Graeme J M Alexander; Roger Williams
Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome.
Hepatology (Baltimore, Md.) 1992;16(2):285-92.
1992: Nikolai Naoumov; R Schneider; T Grötzinger; Maria-Christina Jung; S Miska; Gerd R Pape; Hans Will
Precore mutant hepatitis B virus infection and liver disease.
Gastroenterology 1992;102(2):538-43.
1991: Johnson Y N Lau; V G Bain; Nikolai Naoumov; H M Smith; Graeme J M Alexander; Roger Williams
Effect of interferon-gamma on hepatitis B viral antigen expression in primary hepatocyte culture.
Hepatology (Baltimore, Md.) 1991;14(6):975-9.
1991: Johnson Y N Lau; Nikolai Naoumov; Graeme J M Alexander; Roger Williams
Rapid detection of hepatitis B virus DNA in liver tissue by in situ hybridisation and its combination with immunohistochemistry for simultaneous detection of HBV antigens.
Journal of clinical pathology 1991;44(11):905-8.
1991: Nikolai Naoumov; Johnson Y N Lau; H M Daniels; Graeme J M Alexander; Roger Williams
Detection of HBV-DNA using a digoxigenin-labelled probe. A rapid technique without loss of sensitivity.
Journal of hepatology 1991;12(3):382-5.
1991: Nikolai Naoumov; T Lissichkov; M G Rumi
Hepatitis C virus infection in hemophiliacs.
Annals of internal medicine 1991;114(2):171-2.
1991: J M Tredger; J Grevel; Nikolai Naoumov; C M Steward; A A Niven; B Whiting; Roger Williams
Cyclosporine pharmacokinetics in liver transplant recipients: evaluation of results using both polyclonal radioimmunoassay and liquid chromatographic analysis.
European journal of clinical pharmacology 1991;40(5):513-9.
1990: Nikolai Naoumov; Bernard Portmann; R S Tedder; B Ferns; A L Eddleston; G J Alexander; Roger Williams
Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection.
Gastroenterology 1990;99(4):1248-53.
1989: M Lombard; Nikolai Naoumov; A Bomford; Roger Williams; M Hynes; P Dervan; John Crowe
Optimizing the immunohistochemical signal from the transferrin receptor in liver tissue.
The Histochemical journal 1989;21(4):223-7.
1989: Nikolai Naoumov; J M Tredger; C M Steward; J G O'Grady; J Grevel; A Niven; B Whiting; Roger Williams
Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction.
Gut 1989;30(3):391-6.
1989: B Kiperova; I Grouev; Zahariy Krastev; Nikolai Naoumov; V Minkova; L Mateva; A Maleev
[Role of hepatitis B virus infection in chronic glomerulonephritis].
Annales de médecine interne 1989;140(5):380-2.
1989: M Lombard; A Bomford; M Hynes; Nikolai Naoumov; S Roberts; John Crowe; Roger Williams
Regulation of the hepatic transferrin receptor in hereditary hemochromatosis.
Hepatology (Baltimore, Md.) 1989;9(1):1-5.
1988: Nikolai Naoumov; Graeme J M Alexander; A L Eddleston; Roger Williams
In situ hybridisation in formalin fixed, paraffin wax embedded liver specimens: method for detecting human and viral DNA using biotinylated probes.
Journal of clinical pathology 1988;41(7):793-8.
1988: Nikolai Naoumov; Graeme J M Alexander; John G O'Grady; S Sutherland; P Aldis; Bernard Portmann; Roger Williams
Rapid diagnosis of cytomegalovirus infection by in-situ hybridisation in liver grafts.
Lancet 1988;1(8599):1361-4.
1988: J M Tredger; Nikolai Naoumov; C M Steward; J G O'Grady; J Grevel; A A Niven; andrew william kelman; B Whiting; Roger Williams
Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):512-5.
1986: Nikolai Naoumov; A Gueorgiev; M Ognyanov; A Maleev
Infection with hepatitis delta virus in patients with fulminant hepatitis B and chronic HBsAg carriers in Bulgaria.
Hepato-gastroenterology 1986;33(2):49-51.